Celebrating our 10th anniversary – Unlock our special offer today

Nicotine imports allowed under prescription: Australia regulatory report

In our latest look at e-cig regulations in Australia, we find that at the national level, nicotine is treated as a poison, following the Commonwealth Standard for the Uniform Scheduling of Medicines and Poisons (SUSMP). All nicotine-containing products for therapeutic use must be approved as “registered” medicines in the Australian Register of Therapeutic Goods before they can be marketed. To date, no such approval has been granted. Consumers can import e-cigs containing nicotine in limited quantities for personal use. Since nicotine-free vapour products are considered consumer products and can be sold freely, various state-level regulations have been enacted to protect minors, such as age restrictions, retail licensing and public place usage bans.

I'm already a subscriber
Author default picture


This article was written by one of ECigIntelligence’s international correspondents. We currently employ more than 40 reporters around the world to cover individual vaping markets. For a full list, please see our Who We Are page.

Our Key Benefits

The global e-cigarette market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

ECigIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization